Valuation: Inotiv, Inc.

Market Cap 4L 3L 3L 3L 5L 3.73Cr 6L 37.56L 14.67L 1.83Cr 14.54L 14.22L 6.34Cr P/E 2024
-0.41x
P/E 2025 -0.69x
Enterprise Value 44Cr 38Cr 36Cr 33Cr 62Cr 4.22TCr 63Cr 424.76Cr 165.95Cr 2.07TCr 164.4Cr 160.86Cr 7.17TCr EV / Sales 2024
0.95x
EV / Sales 2025 0.95x
Free-Float
91.44%
Yield 2024 *
-
Yield 2025 -
1 day-26.00%
1 week-26.00%
Current month+7.77%
3 months-96.25%
6 months-97.98%
Current year-98.03%
1 month 0.01
Extreme 0.0072
0.03
Current year 0.01
Extreme 0.007
0.65
1 year 0.01
Extreme 0.007
2.43
3 years 0.01
Extreme 0.007
11.42
5 years 0.01
Extreme 0.007
60.66
10 years 0.01
Extreme 0.007
60.66
Manager TitleAgeSince
Chief Executive Officer 67 12/01/2019
Director of Finance/CFO 61 06/03/2020
Compliance Officer 49 23/10/2023
Director TitleAgeSince
Chairman 71 26/03/2024
Director/Board Member 60 02/07/2018
Director/Board Member 67 12/01/2019
Date Insider Type Main position Quantity % Market Cap.
19/07/26 Others

Director

-74,303 0.2130%
19/07/26 Others

Chief Executive Officer

-13,61,215 3.9017%
19/07/26 Others

Chief Financial Officer

-1,39,616 0.4002%
Change 5-day change 1-year change 3-year change Capi.($)
-26.00%-26.00%-99.51%-99.84% 4L
+1.07%-3.49%-3.25%+12.87% 4.63TCr
-0.67%+0.44%+402.34%+620.78% 4.01TCr
-0.03%+4.83%+10.33%+67.53% 3.63TCr
+0.74%+1.45%+4.20%-8.28% 3.46TCr
+3.14%+1.02%+3.72%+34.86% 2.68TCr
+0.75%-2.24% - - 1.67TCr
-0.06%+12.65%+32.94%+145.31% 1.69TCr
+0.42%-5.52%+0.76%+8.50% 1.31TCr
-1.73%-1.61%-14.22%-31.06% 1.3TCr
Average -2.26%+0.91%+37.48%+83.41% 2.44TCr
Weighted average by Cap. +0.48%+0.77%+74.81%+135.44%

Financials

2024 2025
Net sales 49Cr 43Cr 40Cr 37Cr 69Cr 4.73TCr 70Cr 475.98Cr 185.96Cr 2.32TCr 184.22Cr 180.25Cr 8.03TCr 51Cr 45Cr 42Cr 38Cr 72Cr 4.94TCr 73Cr 497.6Cr 194.41Cr 2.43TCr 192.59Cr 188.44Cr 8.4TCr
Net income -11Cr -9.52Cr -8.86Cr -8.13Cr -15Cr -1.04TCr -16Cr -105.18Cr -41Cr -513.43Cr -41Cr -40Cr -1.78TCr -6.86Cr -6.03Cr -5.61Cr -5.14Cr -9.66Cr -660.87Cr -9.81Cr -67Cr -26Cr -324.9Cr -26Cr -25Cr -1.12TCr
Net Debt 42Cr 37Cr 35Cr 32Cr 60Cr 4.08TCr 61Cr 410.95Cr 160.55Cr 2.01TCr 159.05Cr 155.63Cr 6.94TCr 44Cr 38Cr 36Cr 33Cr 62Cr 4.21TCr 63Cr 424.39Cr 165.8Cr 2.07TCr 164.26Cr 160.72Cr 7.16TCr
Logo Inotiv, Inc.
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Employees
1,996
Date Price Change Volume
17/26/17 $0.0111 -26.00% 2,43,786
16/26/16 $0.0150 +32.74% 70,600
15/26/15 $0.0113 -13.08% 6,30,714
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. NOTVQ Stock